Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.

Wilding CP, Elms ML, Judson I, Tan AC, Jones RL, Huang PH.

Expert Rev Anticancer Ther. 2019 Nov 13:1-21. doi: 10.1080/14737140.2019.1686979. [Epub ahead of print]

PMID:
31665941
2.

The mutational landscape of mucosal melanoma.

Nassar KW, Tan AC.

Semin Cancer Biol. 2019 Oct 23. pii: S1044-579X(19)30286-X. doi: 10.1016/j.semcancer.2019.09.013. [Epub ahead of print] Review.

PMID:
31655118
3.

Partial Patella Tendon Tear in a Middle-Aged Man with No Previous Knee Injuries: A Non-Surgical Approach.

Choi NY, Sim SH, Tan AC, Sirisena D.

Ann Acad Med Singapore. 2019 Aug;48(8):268-273. No abstract available.

4.

Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.

Samson JM, Ravindran Menon D, Smith DE, Baird E, Kitano T, Gao D, Tan AC, Fujita M.

Chem Biol Interact. 2019 Dec 1;314:108822. doi: 10.1016/j.cbi.2019.108822. Epub 2019 Sep 30.

PMID:
31580832
5.

Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines.

Hinz TK, Kleczko EK, Singleton KR, Calhoun J, Marek LA, Kim J, Tan AC, Heasley LE.

Mol Pharmacol. 2019 Dec;96(6):862-870. doi: 10.1124/mol.119.117804. Epub 2019 Sep 25.

6.

Calcium, Diet, Imaging, and Age-Related Macular Degeneration.

Curcio CA, Tan ACS, Lengyel I.

JAMA Ophthalmol. 2019 Sep 19. doi: 10.1001/jamaophthalmol.2019.2725. [Epub ahead of print] No abstract available.

PMID:
31536097
7.

Transcatheter aortic valve replacements alter circulating serum factors to mediate myofibroblast deactivation.

Aguado BA, Schuetze KB, Grim JC, Walker CJ, Cox AC, Ceccato TL, Tan AC, Sucharov CC, Leinwand LA, Taylor MRG, McKinsey TA, Anseth KS.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaav3233. doi: 10.1126/scitranslmed.aav3233.

PMID:
31511425
8.

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.

Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, Frank JG, Kim DJ, George C, Lee YB, Benaim E, Gittleman B, Hartman SJ, Tan AC, Kim J, Pitts TM, Eckhardt SG, Tentler JJ, Diamond JR.

Mol Cancer Ther. 2019 Nov;18(11):1916-1925. doi: 10.1158/1535-7163.MCT-18-1334. Epub 2019 Sep 5.

PMID:
31488700
9.

COMPARISON OF MULTICOLOR IMAGING AND COLOR FUNDUS PHOTOGRAPHY IN THE DETECTION OF PATHOLOGICAL FINDINGS IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.

Tan ACS, Yanagi Y, Cheung GCM.

Retina. 2019 Aug 27. doi: 10.1097/IAE.0000000000002638. [Epub ahead of print]

PMID:
31464882
10.

Data quality audit of a clinical quality registry: a generic framework and case study of the Australian and New Zealand Hip Fracture Registry.

Tan AC, Armstrong E, Close J, Harris IA.

BMJ Open Qual. 2019 Jul 17;8(3):e000490. doi: 10.1136/bmjoq-2018-000490. eCollection 2019.

11.

Chronic Widespread Pain and Fibromyalgia Syndrome: Life-Course Risk Markers in Young People.

Tan AC, Jaaniste T, Champion D.

Pain Res Manag. 2019 May 5;2019:6584753. doi: 10.1155/2019/6584753. eCollection 2019. Review.

12.

Prevalence of trial registration varies by study characteristics and risk of bias.

Tan AC, Jiang I, Askie L, Hunter K, Simes RJ, Seidler AL.

J Clin Epidemiol. 2019 Sep;113:64-74. doi: 10.1016/j.jclinepi.2019.05.009. Epub 2019 May 20. Review.

PMID:
31121304
13.

ReSimNet: Drug Response Similarity Prediction using Siamese Neural Networks.

Jeon M, Park D, Lee J, Jeon H, Ko M, Kim S, Choi Y, Tan AC, Kang J.

Bioinformatics. 2019 May 22. pii: btz411. doi: 10.1093/bioinformatics/btz411. [Epub ahead of print]

PMID:
31116384
14.

Correction: Electromagnetic-Guided Bedside Placement of Nasoenteral Feeding Tubes by Nurses Is Non-Inferior to Endoscopic Placement by Gastroenterologists: A Multicenter Randomized Controlled Trial.

Gerritsen A, de Rooij T, Dijkgraaf MG, Busch OR, Bergman JJ, Ubbink DT, van Duijvendijk P, Erkelens WG, Klos M, Kruyt PM, Bac DJ, Rosman C, Tan AC, Molenaar QI, Monkelbaan JF, Mathus-Vliegen EM, Besselink MG; Collabolators.

Am J Gastroenterol. 2019 Jun;114(6):1012. doi: 10.14309/ajg.0000000000000252. No abstract available.

PMID:
31033519
15.

Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.

Tan AC, McCrary JM, Park SB, Trinh T, Goldstein D.

Support Care Cancer. 2019 Dec;27(12):4771-4777. doi: 10.1007/s00520-019-04781-6. Epub 2019 Apr 10.

PMID:
30972648
16.

Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC).

Tan AC, Teh YL, Lai GGY, Tan DSW.

Expert Rev Anticancer Ther. 2019 Jun;19(6):431-435. doi: 10.1080/14737140.2019.1604228. Epub 2019 Apr 14. No abstract available.

PMID:
30950666
17.

IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.

Gan CP, Sam KK, Yee PS, Zainal NS, Lee BKB, Abdul Rahman ZA, Patel V, Tan AC, Zain RB, Cheong SC.

Cell Oncol (Dordr). 2019 Aug;42(4):477-490. doi: 10.1007/s13402-019-00437-z. Epub 2019 Apr 4.

PMID:
30949979
18.

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.

Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE.

Clin Cancer Res. 2019 May 15;25(10):3141-3151. doi: 10.1158/1078-0432.CCR-18-2953. Epub 2019 Feb 8.

PMID:
30737244
19.

Catheter-directed thrombolysis versus percutaneous mechanical thrombectomy in the management of acute limb ischemia: a single center review.

Muli Jogi RK, Damodharan K, Leong HL, Tan ACS, Chandramohan S, Venkatanarasimha NKK, Irani FG, Patel A, Gogna A, Tay KH, Urlings TAJ.

CVIR Endovasc. 2018;1(1):35. doi: 10.1186/s42155-018-0041-1. Epub 2018 Dec 3.

20.

Future clinical applicability of optical coherence tomography angiography.

Chua J, Tan B, Ang M, Nongpiur ME, Tan AC, Najjar RP, Milea D, Schmetterer L.

Clin Exp Optom. 2019 May;102(3):260-269. doi: 10.1111/cxo.12854. Epub 2018 Dec 11. Review.

PMID:
30537233
21.

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.

Kessler BE, Mishall KM, Kellett MD, Clark EG, Pugazhenthi U, Pozdeyev N, Kim J, Tan AC, Schweppe RE.

Oncogene. 2019 Apr;38(14):2565-2579. doi: 10.1038/s41388-018-0617-1. Epub 2018 Dec 10.

22.

New drug developments in metastatic gastric cancer.

Tan AC, Chan DL, Faisal W, Pavlakis N.

Therap Adv Gastroenterol. 2018 Nov 14;11:1756284818808072. doi: 10.1177/1756284818808072. eCollection 2018. Review.

23.

Management of chronic central serous chorioretinopathy.

Hanumunthadu D, Tan ACS, Singh SR, Sahu NK, Chhablani J.

Indian J Ophthalmol. 2018 Dec;66(12):1704-1714. doi: 10.4103/ijo.IJO_1077_18. Review.

24.

Characteristics and outcomes of oncology unit patients requiring admission to an Australian intensive care unit.

Tan AC, Jacques SK, Oatley M, Guminski AD.

Intern Med J. 2019 Jun;49(6):734-739. doi: 10.1111/imj.14160.

PMID:
30411448
25.

Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration.

Tan ACS, Pilgrim MG, Fearn S, Bertazzo S, Tsolaki E, Morrell AP, Li M, Messinger JD, Dolz-Marco R, Lei J, Nittala MG, Sadda SR, Lengyel I, Freund KB, Curcio CA.

Sci Transl Med. 2018 Nov 7;10(466). pii: eaat4544. doi: 10.1126/scitranslmed.aat4544.

PMID:
30404862
26.

Current status of dialysis and vascular access in Taiwan.

Chen CF, Chen FA, Lee TL, Liao LF, Chen CY, Tan AC, Chan CH, Lin CC.

J Vasc Access. 2019 Jul;20(4):368-373. doi: 10.1177/1129729818807336. Epub 2018 Oct 25.

PMID:
30354908
27.

CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.

Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, Robinson WA, Messersmith WA, Fujita M.

Cancer Res. 2018 Dec 1;78(23):6561-6574. doi: 10.1158/0008-5472.CAN-18-0330. Epub 2018 Oct 8.

PMID:
30297536
28.

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth.

Parrish JK, McCann TS, Sechler M, Sobral LM, Ren W, Jones KL, Tan AC, Jedlicka P.

Oncotarget. 2018 Sep 4;9(69):33110-33123. doi: 10.18632/oncotarget.26011. eCollection 2018 Sep 4.

29.

Far-infrared therapy improves ankle brachial index in hemodialysis patients with peripheral artery disease.

Chen CF, Chen FA, Tan AC, Lee TL, Chan CH, Lin CC.

Heart Vessels. 2019 Mar;34(3):435-441. doi: 10.1007/s00380-018-1259-5. Epub 2018 Sep 18.

PMID:
30229411
30.

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.

Rogers TJ, Christenson JL, Greene LI, O'Neill KI, Williams MM, Gordon MA, Nemkov T, D'Alessandro A, Degala GD, Shin J, Tan AC, Cittelly DM, Lambert JR, Richer JK.

Mol Cancer Res. 2019 Jan;17(1):30-41. doi: 10.1158/1541-7786.MCR-18-0246. Epub 2018 Sep 13.

PMID:
30213797
31.

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma.

Tan AC, Emmett L, Lo S, Liu V, Kapoor R, Carlino MS, Guminski AD, Long GV, Menzies AM.

Ann Oncol. 2018 Oct 1;29(10):2115-2120. doi: 10.1093/annonc/mdy330.

PMID:
30137228
32.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Oct;48(7):761-767. doi: 10.1111/apt.14939. Epub 2018 Aug 15.

33.

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.

Karam SD, Reddy K, Blatchford PJ, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, Bowles DW, Raben D.

Clin Cancer Res. 2018 Oct 15;24(20):4949-4959. doi: 10.1158/1078-0432.CCR-18-0467. Epub 2018 Jul 3.

34.

CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.

Suda K, Murakami I, Yu H, Kim J, Tan AC, Mizuuchi H, Rozeboom L, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR.

Mol Cancer Ther. 2018 Oct;17(10):2257-2265. doi: 10.1158/1535-7163.MCT-17-1279. Epub 2018 Jul 26.

35.

Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.

Oweida A, Hararah MK, Phan A, Binder D, Bhatia S, Lennon S, Bukkapatnam S, Van Court B, Uyanga N, Darragh L, Kim HM, Raben D, Tan AC, Heasley L, Clambey E, Nemenoff R, Karam SD.

Clin Cancer Res. 2018 Nov 1;24(21):5368-5380. doi: 10.1158/1078-0432.CCR-18-1038. Epub 2018 Jul 24.

36.

A Metal Stent in a Colostomy Obstruction.

van Gils NA, Cornelissen JGHM, Tan ACITL.

GE Port J Gastroenterol. 2018 Jun;25(4):214-215. doi: 10.1159/000481625. Epub 2018 Jan 10. No abstract available.

37.

GSEA-InContext: identifying novel and common patterns in expression experiments.

Powers RK, Goodspeed A, Pielke-Lombardo H, Tan AC, Costello JC.

Bioinformatics. 2018 Jul 1;34(13):i555-i564. doi: 10.1093/bioinformatics/bty271.

38.

Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions.

Suda K, Kim J, Murakami I, Rozeboom L, Shimoji M, Shimizu S, Rivard CJ, Mitsudomi T, Tan AC, Hirsch FR.

J Thorac Oncol. 2018 Oct;13(10):1496-1507. doi: 10.1016/j.jtho.2018.05.039. Epub 2018 Jun 19.

39.

AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Pei S, Minhajuddin M, Adane B, Khan N, Stevens BM, Mack SC, Lai S, Rich JN, Inguva A, Shannon KM, Kim H, Tan AC, Myers JR, Ashton JM, Neff T, Pollyea DA, Smith CA, Jordan CT.

Cell Stem Cell. 2018 Jul 5;23(1):86-100.e6. doi: 10.1016/j.stem.2018.05.021. Epub 2018 Jun 14.

40.

Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine.

Kim J, Yoo M, Shin J, Kim H, Kang J, Tan AC.

Int J Genomics. 2018 Mar 22;2018:7697356. doi: 10.1155/2018/7697356. eCollection 2018.

41.

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.

Hintzsche JD, Yoo M, Kim J, Amato CM, Robinson WA, Tan AC.

BMC Med Genomics. 2018 Apr 20;11(Suppl 2):26. doi: 10.1186/s12920-018-0350-1.

42.

Unexpected amebic colitis presenting with rectal bleeding and perforation after biopsy.

de Leijer JH, Tan ACITL, Mulder B, Zomer SF.

Gastrointest Endosc. 2018 Sep;88(3):565-566. doi: 10.1016/j.gie.2018.04.2345. Epub 2018 Apr 22. No abstract available.

PMID:
29689256
43.

Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.

Yoo M, Shin J, Kim H, Kim J, Kang J, Tan AC.

Comput Methods Programs Biomed. 2019 Jun;174:33-40. doi: 10.1016/j.cmpb.2018.04.002. Epub 2018 Apr 4.

44.

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.

Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW.

Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3.

45.

Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.

Smeets XJNM, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, Zegers M, Bruno MJ, Besselink MGH, Vleggaar FP, van der Hulst RWM, Poen AC, Heine GDN, Venneman NG, Kolkman JJ, Baak LC, Römkens TEH, van Dijk SM, Hallensleben NDL, van de Vrie W, Seerden TCJ, Tan ACITL, Voorburg AMCJ, Poley JW, Witteman BJ, Bhalla A, Hadithi M, Thijs WJ, Schwartz MP, Vrolijk JM, Verdonk RC, van Delft F, Keulemans Y, van Goor H, Drenth JPH, van Geenen EJM; Dutch Pancreatitis Study Group.

Trials. 2018 Apr 2;19(1):207. doi: 10.1186/s13063-018-2583-x.

46.

Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.

Keysar SB, Eagles JR, Miller B, Jackson BC, Chowdhury FN, Reisinger J, Chimed TS, Le PN, Morton JJ, Somerset HL, Varella-Garcia M, Tan AC, Song JI, Bowles DW, Reyland ME, Jimeno A.

Clin Cancer Res. 2018 Jun 15;24(12):2935-2943. doi: 10.1158/1078-0432.CCR-17-3871. Epub 2018 Mar 19.

47.

Reply.

Tan ACS, Freund KB, Sarraf D.

Retina. 2018 May;38(5):e37-e38. doi: 10.1097/IAE.0000000000002148. No abstract available.

PMID:
29554079
48.

GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems.

Lee BKB, Gan CP, Chang JK, Tan JL, Fadlullah MZ, Abdul Rahman ZA, Prime SS, Gutkind JS, Liew CS, Khang TF, Tan AC, Cheong SC.

J Dent Res. 2018 Jul;97(8):909-916. doi: 10.1177/0022034518759038. Epub 2018 Mar 7.

PMID:
29512401
49.

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.

Pilling AB, Kim J, Estrada-Bernal A, Zhou Q, Le AT, Singleton KR, Heasley LE, Tan AC, DeGregori J, Doebele RC.

Oncotarget. 2018 Jan 16;9(10):8823-8835. doi: 10.18632/oncotarget.24260. eCollection 2018 Feb 6.

50.

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.

Klauck PJ, Bagby SM, Capasso A, Bradshaw-Pierce EL, Selby HM, Spreafico A, Tentler JJ, Tan AC, Kim J, Arcaroli JJ, Purkey A, Messersmith WA, Kuida K, Eckhardt SG, Pitts TM.

BMC Cancer. 2018 Feb 5;18(1):136. doi: 10.1186/s12885-018-4036-z.

Supplemental Content

Support Center